ACE and Alzheimer disease: With regards to ACE-Is, Lee et al. (2020) demonstrated that the ability of captopril to suppress AD-related phenotypes in flies could be recapitulated by a null mutation in Acer demonstrating that Acer or a downstream effector of Acer, is the target of captopril.